(Q34052087)

30 July 2017

1 reference

title

Outpatient parenteral inotropic therapy for advanced heart failure (English)

1 reference

30 July 2017

0 references

Young JB

1

1 reference

30 July 2017

Moen EK

series ordinal

2

1 reference

30 July 2017

publication date

1 August 2000

1 reference

The Journal of Heart and Lung Transplantation

30 July 2017

published in

1 reference

30 July 2017

volume

19

1 reference

30 July 2017

issue

8 Suppl

1 reference

30 July 2017

page(s)

S49-57

1 reference

Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Hemodynamic effect of dobutamine in patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Cardiovascular effects of dobutamine in severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Long-term benefit of dobutamine in patients with congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Drug-induced conditioning in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Intermittent ambulatory dobutamine infusions for patients awaiting cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Intermittent dobutamine infusion in severe chronic heart failure in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2899%2900107-2

7 January 2021

10.1016/S1053-2498(99)00107-2

Identifiers

DOI

1 reference

30 July 2017

1 reference